Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome - sprookjes - yvandenbroek - TriplyDB

Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome

Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome

http://www.wikidata.org/entity/Q27478087

about

Full-Length Characterization of Hepatitis C Virus Subtype 3a Reveals Novel Hypervariable Regions under Positive Selection during Acute Infection Quasispecies evolution in NS5A region of hepatitis C virus genotype 1b during interferon or combined interferon-ribavirin therapy.Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.Clinical impact of hepatitis B and C virus envelope glycoproteins.Genetic diversity of hepatitis C virus quasispecies in chronic renal failure patients in Midwest Brazil.Hepatitis C virus envelope glycoprotein signatures are associated with treatment failure and modulation of viral entry and neutralization.

P2860

Q27490315-796BC6A4-2E37-4A21-AB37-6C75D3872A89 Q34099523-30220858-76CD-4038-BCA1-05AA475DE03A Q35053127-8F61A903-9709-4E91-B60A-B2E16F3774E7 Q38083515-3CB4A1AE-D2BA-4CC8-AB17-1DF02EAAD0E1 Q42235615-06AE894D-3055-450C-BEA6-6FC5D53A15D7 Q42988476-9F0B4C37-8AFF-47F9-A97A-C49D6D8B0F85

P2860

Significance of Pretreatment Analysis of Hepatitis C Virus Genotype 1b Hypervariable Region 1 Sequences To Predict Antiviral Outcome

http://www.wikidata.org/entity/Q27478087

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@ast

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@en

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@nl

type

label

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@ast

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@en

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@nl

prefLabel

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@ast

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@en

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@nl

P1433

Q27478087-D034B79C-86AF-447E-AF76-477109E93B2E

P1476

Q27478087-B95D2825-F223-44FB-B84A-3079E583A77B

P2093

Q27478087-4A197CA2-D426-4D5C-906B-78C66D3F7828

Q27478087-8374A16E-831B-4369-8289-F4C848241B2E

Q27478087-A2B557EE-68CF-4162-88C2-C84DA5F2AEBE

Q27478087-B63FD561-C073-4186-89F5-C5F0F9CA1F31

Q27478087-B7831B14-8E60-4599-8B86-E789256D9046

Q27478087-E10CDEBD-627D-40D5-9947-B54CEA983A77

P2860

Q27478087-04B00A0C-9A9E-4D2A-A606-B7ABE92BF2FC

Q27478087-08BE33A5-D7EA-4EDF-988A-C96997DADE1A

Q27478087-0CBC441B-924E-4A36-A7C0-A98A7503E06C

Q27478087-11ACD2AA-0613-45D8-9003-D428352354AE

Q27478087-28397135-EC15-465B-84E8-185736AE0AEA

Q27478087-3183C2FC-0BD0-4D8E-9AF9-E2D5316CC0B8

Q27478087-3418B0DF-60AB-4928-98E4-69FFCA241435

Q27478087-484771B4-AA90-48D7-807B-FC4DBCF30D31

Q27478087-4B29283D-0BAE-4199-8DCC-D559A3797ECD

Q27478087-521CEC47-AED0-4D77-894F-878D19EDE2CD

P304

Q27478087-4B05DFDA-571F-4467-8D6C-8508365E96AC

P31

Q27478087-DD149F4F-8BF1-42D7-995B-6936002F99FB

P356

Q27478087-56DF8407-AF86-40B3-834F-2B8CB49836FC

P407

Q27478087-54B62C6E-657C-463A-B32C-9A57C45A7CC3

P433

Q27478087-76F34636-DE97-4E49-9158-EAF2EB74D5B4

P478

Q27478087-C1D6F6FC-6554-43F6-AF3F-EDD0402B957C

P577

Q27478087-6032832D-7C5A-4C63-9875-BCC24C8C260E

P698

Q27478087-92AC4A72-35EB-40EC-8162-9B509EB3301C

P921

Q27478087-0329114C-75B7-479F-9284-A8164E2223D4

P932

Q27478087-1749446E-5CEA-448D-8528-A38277ECD5AF

P356

JCM.41.8.3615-3622.2003

P1433

Journal of Clinical Microbiology

P1476

Significance of Pretreatment A ...... s To Predict Antiviral Outcome

@en

P2093

Alain Goudeau

http://www.w3.org/2001/XMLSchema#string

Alain Moreau

http://www.w3.org/2001/XMLSchema#string

Catherine Gaudy

http://www.w3.org/2001/XMLSchema#string

Francoise Lunel

http://www.w3.org/2001/XMLSchema#string

Pascal Veillon

http://www.w3.org/2001/XMLSchema#string

Stephanie Temoin

http://www.w3.org/2001/XMLSchema#string

P2860

The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus.

A simple method for displaying the hydropathic character of a protein

Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: hypervariable region 1 as a decoy

Evolution of hepatitis C virus quasispecies in hypervariable region 1 and the putative interferon sensitivity-determining region during interferon therapy and natural infection.

Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy.

Evolution of the hepatitis C virus second envelope protein hypervariable region in chronically infected patients receiving alpha interferon therapy

Conservation of the Conformation and Positive Charges of Hepatitis C Virus E2 Envelope Glycoprotein Hypervariable Region 1 Points to a Role in Cell Attachment

Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants

Hepatitis C virus-like particle morphogenesis

Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing

P304

3615-22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.41.8.3615-3622.2003

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

41

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12904364

http://www.w3.org/2001/XMLSchema#string

P921

P932

179854

http://www.w3.org/2001/XMLSchema#string